These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8464648)

  • 61. Ceftibuten: an overview.
    Owens RC; Nightingale CH; Nicolau DP
    Pharmacotherapy; 1997; 17(4):707-20. PubMed ID: 9250548
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment of pharyngitis and tonsillitis with cefprozil: review of three multicenter trials.
    McCarty JM; Renteria A
    Clin Infect Dis; 1992 Jun; 14 Suppl 2():S224-30; discussion S231-2. PubMed ID: 1617042
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative studies of cefprozil in the management of skin and soft-tissue infections.
    Nolen T
    Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):866-71. PubMed ID: 7889961
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ceftibuten: minimal inhibitory concentrations, postantibiotic effect and beta-lactamase stability--a rationale for dosing programs.
    Neu HC
    Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S88-92. PubMed ID: 7567316
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Bacteriological, pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field].
    Toyonaga Y; Ishihara T; Sano T; Tezuka T; Nakamura H
    Jpn J Antibiot; 1993 Jul; 46(7):604-28. PubMed ID: 8371496
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Clinical study on cefprozil in pediatrics].
    Iwai N; Miyazu M; Nakamura H; Kasai K
    Jpn J Antibiot; 1992 Nov; 45(11):1537-57. PubMed ID: 1494236
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Bacteriological and clinical evaluation of cephalosporin preparations in 10 years of experience].
    Catalano G; Abbate GF; Gattoni A; Coraggio F; Altucci P
    G Ital Chemioter; 1977; 24(1-2):39-48. PubMed ID: 615761
    [No Abstract]   [Full Text] [Related]  

  • 68. Spectrum of antibiogram against pathogens related to respiratory tract infections with a special reference to ceftibuten: a multicentric study.
    Sengupta S; Deodhar L; Kapoor H; Badrinath S; Menon SS
    J Indian Med Assoc; 2000 Apr; 98(4):196-7. PubMed ID: 11016192
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cefuroxime axetil: an updated review of its use in the management of bacterial infections.
    Scott LJ; Ormrod D; Goa KL
    Drugs; 2001; 61(10):1455-500. PubMed ID: 11558834
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Pharmacokinetics and clinical effects of cefdinir 5% fine granules in pediatrics].
    Motohiro T; Handa S; Yamada S; Oki S; Tsumura N; Yoshinaga Y; Aramaki M; Shimada Y; Kawakami A; Koga T
    Jpn J Antibiot; 1990 Oct; 43(10):1813-35. PubMed ID: 2086819
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical evaluation of cephradine, a new oral cephalosporin.
    Scholand JF; Hodges GR; Fass RJ; Saslaw S
    Am J Med Sci; 1974 Feb; 267(2):111-6. PubMed ID: 4595266
    [No Abstract]   [Full Text] [Related]  

  • 72. Cefpodoxime proxetil: a new, broad-spectrum, oral cephalosporin.
    Chocas EC; Paap CM; Godley PJ
    Ann Pharmacother; 1993 Nov; 27(11):1369-77. PubMed ID: 8286813
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
    Ball P
    Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):851-6. PubMed ID: 7889959
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pathogen shifts and changing cure rates for otitis media and tonsillopharyngitis.
    Pichichero ME
    Clin Pediatr (Phila); 2006 Jul; 45(6):493-502. PubMed ID: 16893853
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections.
    Balfour JA; Todd PA; Peters DH
    Drugs; 1995 May; 49(5):794-850. PubMed ID: 7601015
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A non-comparative, multicentre study of cefepime in the treatment of serious bacterial infections.
    Mouton Y; Chidiac C; Humbert G; Leroy J; Veyssier P; Modai J; Bertrand A; Dellamonica P; Micoud M; Stahl JP
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():133-40. PubMed ID: 8150757
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Significant role of new oral cephem antibiotics. Focused on cefditoren pivoxil: discussion].
    Shimada K
    Jpn J Antibiot; 1994 Aug; 47(8):951-66. PubMed ID: 7933539
    [No Abstract]   [Full Text] [Related]  

  • 78. Safety and efficacy of cefprozil as part of a parenteral-oral antibiotic regimen for the treatment of suppurative skeletal infections in children.
    Trujillo M; Ehrett S; Hoyt-Sehnert MJ; Shelton S; McCracken GH
    Clin Infect Dis; 1996 Oct; 23(4):843. PubMed ID: 8909865
    [No Abstract]   [Full Text] [Related]  

  • 79. Comparative trial of cefprozil vs. amoxicillin clavulanate potassium in the treatment of children with acute otitis media with effusion.
    Arguedas AG; Zaleska M; Stutman HR; Blumer JL; Hains CS
    Pediatr Infect Dis J; 1991 May; 10(5):375-80. PubMed ID: 1906160
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cephacetrile--a new cephalosporin antibiotic.
    Hodson AH; Holloway WJ
    Int J Clin Pharmacol; 1973 Feb; 7(1):89-94. PubMed ID: 4699390
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.